CHINA MEDICAL CITY (CMC) SPECIAL PROMOTION CONFERENCE
Time：2023-05-03 Look：589
If you are interested in China market, if your company is looking for business opportunities in China, or if you want to know about the drug/medtech regulation and registration process and clinical trial application process in China, this CMC promotion conference in Lausanne is an absolutely opportunity for you to not only get your anwsers but also to get right path to China market.
Date and Time:26.05.2023 Friday 15.00-18.00
Address: Aquatis Hotel, Rte de Berne 148, 1010 Lausanne
AGENDA:
15.00 - 15.30 Arrive and Registration
15.30 - 15.35 Conference Introduction
15.35 - 15.40 Welcome Address
15.40 - 16.00 Address by Guest Representatives (TBD)
16.00 - 16.20 CMC Promotion
16.20 - 16.40 Q&A
16.40 - 18.00 Apèro
Organizer:
China Medical City (CMC)
Co-organizer:
Swiss-Sino Innovation Center (SSIC),
Sino European Federation of Life Sciences (SEFL)
Supporting organization:
Chinese Association of Science and Technology, Switzerland (CASTS)
Interested in joining us? Preregistration is required.
Registration Now
About CMC:
China Medical City (CMC) is located in Taizhou (Jiangsu Province), an important city in the Yangtze River Delta Zone, with an overall planning area of 30 square kilometers. It consists of several functional areas such as scientific research and development area, production and manufacturing area, exhibition and trading area, health care area, education and teaching area, and comprehensive supporting area.
It is China's first national-level medical and pharmaceutical high-tech zone, jointly established by the Ministry of Science and Technology, the National Health and Family Planning Commission, the National Medical Products Administration, the State Administration of Traditional Chinese Medicine and the Jiangsu Provincial Government.
At present, more than 70 well-known universities and pharmaceutical R&D institutions havesettled in the CMC, and more than 1,200 well-known pharmaceutical companies, such as Nestle, AstraZeneca, Takeda, Boehringer Ingelheim, Sanofi, Pasteur, CSPC, Neptune Pharmaceuticals, Walvax Biotechnology, Mabpharm, Sinovetah, have successively settled down; more than 2,100 "world-class, domestic leading" pharmaceutical innovations have successfully applied for new drug registration; and more than 4,300 high-level talents have been attracted to live and work here.
Many professional platforms for new drug creation, animal experiments, new drug testing, new drug pilot tests, clinical trials, data management and analysis, small molecules, macromolecules, and pharmaceutical CMO processing have been established and operated in compliance with international standards.
CMC and Taizhou Pharmaceutical High-tech Zone has become the first choice for the international biomedical industry sectors in China.
CMC will continue to provide with complete and efficient process-based services with focusing on the registration and settlement of companies, technology incubation, new drug declaration, and financial support.
